Cooperative Group Affiliations

Research

NH-BMT participates in several different types of trials, including trials through larger cooperative groups, collaborations with academic-university institutions, pharmaceutical-based trials, and trials in which the NSH-BMT physicians design a study to ask and hopefully answer a certain question.

Cooperative Groups

Bone Marrow Transplant Clinical Trials Network (BMT-CTN)
The BMT-CTN is a cooperative group funded by the National Institutes of Health (NCI) to develop and conduct essential phase II and III trials in hematopoietic cell transplantation. From July 2011 to July 2024, NH-BMT was awarded a BMT CTN Core clinical center grant. Our program is now an affiliate member and has access to all BMT CTN clinical trials.

Resource for Clinical Investigation (RCI)
The Center for International Blood and Marrow Transplant Research (CIBMTR) formed the Resource for Clinical Investigation in Blood and Marrow Transplant (RCI BMT) as a way to provide statistical expertise and data management services for multi-center phase I and II trials. Usually, less than 10 centers participate in these phase I & II trials. The results of the Phase I & II RCI studies may pave the way for future, larger Phase III studies conducted by the BMT-CTN.

Collaborations with Academic Institutions

NH-BMT physicians routinely collaborate with other academic centers so patients can have access to innovative clinical trials close to home.

Investigator-Initiated Clinical Trials
NH-BMT physicians actively write and conduct their own research studies. This type of study is called an investigator-initiated clinical trial. Our initiatives and collaborations with other NCI-designated comprehensive cancer centers, which include Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, University of California at San Diego, Moores Medical Center, and Moffitt Cancer Center, allow us to provide patients with access to the most promising new drugs, biologics, and cellular therapies.